PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34 + hematopoietic progenitor cells

Cell Biology and Toxicology

Volumn 22, Issue 4, 2006, Pages 229-241

  Gross, S A ^a,d   Zheng, J H ^a   Le, A T ^a   Kerzic, P J ^a   Irons, R D ^a,b,c,d,e  

^a Molecular Toxicology and Environmental Health Sciences Program   (United States)

^b School of Medicine   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d FUDAN UNIVERSITY   (China)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

CD34 +; Hematopoietic; Human; Hydroquinone; Phosphorylation; PU.1

Indexed keywords

BENZENE; CD34 ANTIGEN; HYDROQUINONE; PHOSPHATASE; TRANSCRIPTION FACTOR PU 1;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION;

ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROQUINONES; MICROSCOPY, FLUORESCENCE; MONOCYTES; MYELOID CELLS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; STEM CELLS; TRANS-ACTIVATORS;

EID: 33745888434     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-006-0128-7     Document Type: Article

References (53)

1. Behre G, Whitmarsh AJ, Coghlan MP, et al. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem. 1999;274:4939-46.
2. Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB. Regulation of human neutrophil granule protein expression. Curr Opin Hematol. 2001;8:23-7.
3. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368-76.
4. Carey JO, Posekany KJ, deVente JE, Pettit GR, Ways DK. Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition. Blood. 1996;87:4316-24.
5. Celada A, Borras FE, Soler C, et al. The transcription factor PU.1 is involved in macrophage proliferation. J Exp Med. 1996;184:61-9.
6. Colagiovanni DB, Stillman WS, Irons RD. Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to Steel or White Spotted mutations in mice. Proc Natl Acad Sci USA. 1993;90:2803-6.
7. Cronkite EP, Drew RT, Inoue T, Hirabayashi Y, Bullis JE, Hematotoxicity and carcinogenicity of inhaled benzene. Environ Health Perspect 1989;82:97-108.
8. Cuneo A, Fagioli F, Pazzi I, et al. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leuk Res. 1992;16:789-96.
9. Dahl R, Simon MC. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells Mol Dis. 2003;31:229-33.
10. DeKoter RP, Walsh JC, Singh H. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/ macrophage progenitors. EMBO J. 1998;17:4456-68.
11. Delgado MD, Hallier M, Meneceur P, Tavitian A, Moreau-Gachelin F. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides. Oncogene. 1994;9:1723-7.
12. Dempster AM, Snyder CA. Kinetics of granulocyte and erythroid progenitor cells are affected differently by short-term, low-level benzene exposure. Arch Toxicol 1991;65:556-61.
13. Du J, Stankiewicz MJ, Liu Y, et al. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem. 2002;277:43481-94.
14. Eichbaum QG, Iyer R, Raveh DP, Mathieu C, Ezekowitz RA. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med. 1994;179:1985-96.
15. Eisbacher M, Holmes ML, Newton A, et al. Protein-protein Interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocytic- specific genes through cooperative DNA binding. Mol Cel Biol. 2003;23(10):3427-41.
16. Fisher RC, Scott EW. Role of PU.1 in hematopoiesis. Stem Cells. 1998;16:25-37.
17. Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBPα, -β, and -δ during granulocyte-lineage specification. Proc Natl Acad Sci USA. 1996;93:10838-43.
18. Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982;60:404-11.
19. + human bone marrow cells in liquid culture. Eur J Haematol. 1997;59:318-26.
20. Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol. 1996;16:1676-86.
21. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang D-E, Tenen DG. PU.1 (SPI-1) and C/EBPα regulate expression of the granulocyte macrophage colony-stimulating factor receptor α gene. Mol Cell Biol. 1995;15:5830-45.
22. Iida H, Towatari M, Iida M, et al. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts. Int J Hematol. 2000;71:153-8.
23. Irons RD. Benzene-induced myelotoxicity: application of flow cytofluorometry for the evaluation of early proliferative change in bone marrow. Environ Health Perspect. 1981;39:39-49.
24. Irons RD, Stillman WS. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells. 1993;11:235-42.
25. Irons RD, Stillman WS. The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentiation. Eur J Haematol. 1996a;57(Supplement 60):119-24.
26. Irons RD, Stillman WS. Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environ Health Perspect. 1996b;104(Supplement 6):1247-50.
27. Irons RD, Stillman WS. The process of leukemogenesis. Environ Health Perspect. 1996c;104:1239-46.
28. Irons RD, Stillman WS, Colagiovanni DB, Henry VA. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA. 1992;89:3691-5.
29. Li Y, Okuno Y, Zhang P, et al. Regulation of the PU.1 gene by distal elements. Blood. 2001;98:2958-65.
30. Lodie TA, Savedra R Jr, Golenbock DT, Van Beveren CP, Maki RA, Fenton MJ. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J Immunol. 1997;158:1848-56.
31. Mao C, Ray-Gallet D, Tavitian A, Moreau-Gachelin F. Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene. 1996;12:863-73.
32. Marden CM, Stefanidis D, Cunninghame-Graham DS, Casimir CM. Differentiation-dependent up-regulation of p47(phox) gene transcription is associated with changes in PU.1 phosphorylation and increased binding affinity. Biochem Biophys Res Commun. 2003;305:193-202.
33. McIvor Z, Hein S, Fiegler H, et al. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. Exp Hematol. 2003;31:39-47.
34. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998;12:2403-12.
35. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood. 2000;95:2543-51.
36. Perez C, Coeffier E, Moreau-Gachelin F, Wietzerbin J, Benech PD. Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fcγ receptor. Mol Cell Biol. 1994;14:5023-31.
37. Pongubala JMR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol Cell Biol. 1992;12:368-78.
38. Ray-Gallet D, Mao C, Tavitian A, Moreau-Gachelin F. DNA binding specificties of Spi-1/PU.1 and Spi-B transcription factors and identification of a SPi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene. 1995;11:303-13.
39. Reddy VA, Iwana A, Iotzova G, et al. Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood. 2002;100:483-90.
40. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398-411.
41. Rieske P, Pongubala JM. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J Biol Chem. 2001;276:8460-8.
42. 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci USA. 1995;92:801-5.
43. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573-7.
44. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88:1234-47.
45. Srikanth S, Rado, TA. PU.1 regulates the expression of the human neutrophil elastase gene. Biochim Biophys Acta. 1998;1398:215-23.
46. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci USA. 1994;91: 7932-6.
47. Wang JM, Lai MZ, Yang-Yen HF. Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway. Mol Cell Biol. 2003;23:1896-909.
48. Xue Y, Alford P, Shackelford RE. Protein kinase C activation increases binding of transcription factor PU.1 in murine tissue macrophages. Biochem Biophys Res Commun. 1999;254:211-4.
49. Zhang D-E, Fujioka K-I, Hetherington CJ, et al. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol. 1994;14:8085-95.
50. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators : GATA proteins repress PU.1. Proc Natl Acad Sci USA. 1999;96:8705-10.
51. Zhang P, Zhang XB, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 2000;96:2641-48.
52. Zhang P, Nelson E, Radomska HS, et al. Induction of granulocytic differentiation by 2 pathways. Blood. 2002;99:4406-12.
53. Zheng JH, Pyatt DW, Gross SA, Le AT, Kerzic PJ, Irons RD. Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells. Leukemia. 2004;18(7):1296-304.